GLOBAL INDUSTRY INSIGHT: Diabetic Retinopathy Market Trends, Size, Share, Development, Growth

and Demand Forecast to 2020

© P&S Market Research. All rights reserved 2

Global Diabetic Retinopathy Market Size, Share, Development,

Growth and Demand Forecast to 2020

Diabetic retinopathy refers to an eye disorder that damages or harms the blood vessels of the retina. Diabetic

retinopathy can cause permanent blindness. Chronic diabetes is a major root of diabetic retinopathy. High

glucose level in the blood can damage blood vessels in the retina. Diabetic retinopathy can also cause diabetic

macular edema: a medical condition led to the leakage of fluid from the previously injured blood vessels or minute

or delicate blood vessels near the back of the eye, this disease can result in inflammation near the eye and

blurred vision.

To know more visit: https://www.psmarketresearch.com/market-analysis/diabetic-retinopathy-market

The treatment procedure of diabetic retinopathy depends on the various stages of diabetic retinopathy. It is one of

the most dominant reasons of blindness in U.S adults. According to WHO, about 347 million patients were

suffering from diabetes globally as of 2012, and among those 347 million patients 11% of those were effected

from diabetic retinopathy. In the U.S. alone, there were 4.1 million people were impacted from the diabetic

retinopathy as of 2012.

North America was the largest market for diabetic retinopathy in 2014. The market dominance of North America is

attributed to the high obesity rate and large diabetic patients in this region. Moreover the supportive government

initiative is also one of the important drivers of the market in this region. Europe was the second largest market of

diabetic retinopathy in 2014, the large population of baby boomers in Europe is one of the dominate growth

factors for the diabetic retinopathy market in this region. Asia Pacific is expected to show the highest growth over

the next five years. The lucrative growth of the diabetic retinopathy market in Asia Pacific is attributed to the

presence of a large number of diabetic patients in India and China. Moreover, growing health awareness coupled

with rising expenditure on healthcare services is also fueling the diabetic retinopathy market in this region.

Country wise the U.S. is the largest market of diabetic retinopathy in North America. Germany, Spain, Italy, U.K

and France are some of the major diabetic retinopathy market in Europe. China, Japan, India are some of the

major market diabetic retinopathy in Asia Pacific region. Under Rest of the World section Brazil is the largest

market of diabetic retinopathy.

Global increase in the diabetes patients, large population of baby boomers, and changing lifestyle in developing

countries are some of the dominant factors driving diabetic retinopathy market. In addition the increased health

awareness and rising disposable income in developing countries has increased the advanced healthcare

services, affordability; which interns driving the market of diabetic retinopathy. The rising awareness towards the

treatment of diabetic retinopathy and advancement of patient monitoring through electronic medical record in

ophthalmology are some of recent market trend in the diabetic retinopathy market.

Based on the disease type the global diabetic retinopathy market can be broadly classified as non-proliferative

diabetic retinopathy, and proliferative retinopathy. Based on the various treatment method the global diabetic

© P&S Market Research. All rights reserved 3

Global Diabetic Retinopathy Market Size, Share, Development,

Growth and Demand Forecast to 2020

retinopathy market cab be broadly classified as Laser surgery, corticosteroids injection, anti-VEGF drugs, and

others

Based on the different drug use in the global diabetic retinopathy market the market can be bifurcated as ATL-

1103, Lycium Anti-Angiogenic Proteoglycan, ocriplasmin (recombinant), STP-601, BI-30089, OC-10X, and

Squalamine Lactate.

Request for Table of Content: https://www.psmarketresearch.com/enquiry-form.php?enqid=244&title=TOC

Some of the major players operating in the global diabetic retinopathy market include, Bayer AG, Pfizer Inc., F.

Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., Novartis AG, Valeant Pharmaceuticals International

Inc., Abbott Laboratories Ltd., Alimera Sciences Inc., Ampio Pharmaceuticals Inc., Bausch & Lomb Inc.,

Boehringer Ingelheim GmbH, iCo Therapeutics Inc., Lupin Ltd., Parexel International Corp., Quark

Pharmaceuticals Inc., Thrombogenics NV, and Vitreoretinal Technologies Inc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for

various geographies around the globe. We provide market research reports, industry forecasting reports,

business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate

forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through

their interaction with leading companies of the concerned domain. We help our clients with B2B market research

and assist them in identifying various windows of opportunity, and framing informed and customized business

expansion strategies in different regions.

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com